Premium
BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005
Author(s) -
Pozniak AL,
Miller RF,
Lipman MCI,
Freedman AR,
Ormerod LP,
Johnson MA,
Collins S,
Lucas SB
Publication year - 2005
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1111/j.1468-1293.2005.00293.x
Subject(s) - medicine , tuberculosis , rifampicin , isoniazid , coinfection , mycobacterium tuberculosis , bedaquiline , regimen , intensive care medicine , drug resistance , gold standard (test) , human immunodeficiency virus (hiv) , immunology , pathology , microbiology and biotechnology , biology
AL Pozniak, RF Miller, MCI Lipman, AR Freedman, LP Ormerod, MA Johnson, S Collins and SB Lucas, on behalf of the BHIVA Guidelines Writing Committee Chelsea and Westminster NHS Healthcare Trust, London, UK, Centre for Sexual Health and HIV Research, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, University College London, London, UK, Royal Free Hospital, London, UK, Cardiff University School of Medicine, Cardiff, UK, Blackburn Royal Infirmary, Blackburn, Lancashire, UK, HIV i-Base, London, UK, Department of Histopathology, GKT School of Medicine, St Thomas’ Hospital, London, UK